Brevan Howard Capital Management LP Haemonetics Corp Transaction History
Brevan Howard Capital Management LP
- $17 Billion
- Q3 2025
A detailed history of Brevan Howard Capital Management LP transactions in Haemonetics Corp stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 44,547 shares of HAE stock, worth $3.27 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
44,547
Previous 18,485
140.99%
Holding current value
$3.27 Million
Previous $1.38 Million
57.43%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding HAE
# of Institutions
339Shares Held
50.2MCall Options Held
666KPut Options Held
395K-
Black Rock Inc. New York, NY5.96MShares$438 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.83MShares$355 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY3.67MShares$270 Million0.14% of portfolio
-
Aqr Capital Management LLC Greenwich, CT2.13MShares$156 Million0.07% of portfolio
-
State Street Corp Boston, MA1.8MShares$132 Million0.0% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.77B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...